Templeton Backs Sun Pharmaceutical Bid for Taro

Mark Mobius, chairman of Templeton Asset Management Ltd., backed Sun Pharmaceuticals Ltd.’s year-long bid to buy Israeli drugmaker Taro Pharmaceutical Industries Ltd., saying he wants the deal completed “as fast as possible.”
Bloomberg